Related Experiment Video
Updated: Feb 13, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control Study
Francesco Ursini1,2, Salvatore D Angelo3, Emilio Russo1
1Department of Health Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Insights
Complement C3 levels may help predict Type 2 Diabetes (T2DM) in Rheumatoid Arthritis (RA) patients. Higher C3 levels, along with longer RA duration, indicate an increased likelihood of comorbid T2DM.
Area of Science:
- Rheumatology
- Endocrinology
- Immunology
Background:
- Complement C3 is a potential biomarker for cardiometabolic risk in the general population.
- Rheumatoid Arthritis (RA) patients have an increased risk of developing Type 2 Diabetes (T2DM).
Purpose of the Study:
- To investigate the correlation between complement C3 levels and the presence of T2DM in RA patients.
- To assess the predictive value of complement C3 for T2DM in RA.
Main Methods:
- Study included 40 RA patients with T2DM (RA/T2DM+) and 80 RA patients without T2DM (RA/T2DM-).
- Analyzed demographic data, disease characteristics (RA duration, disease activity), inflammatory markers (ESR, CRP), and complement C3 levels.
- Utilized logistic regression and ROC curve analysis to evaluate predictors of T2DM.
Main Results:
- RA/T2DM+ patients were older, had longer RA duration, and higher disease activity compared to RA/T2DM- patients.
- Significantly higher levels of ESR, CRP, and complement C3 were observed in the RA/T2DM+ group.
- Longer RA duration, ESR, and C3 levels were associated with an increased likelihood of T2DM. The combination of RA duration and C3 demonstrated strong predictive value (AUC = 0.89).
Conclusions:
- Complement C3 levels can predict the presence of T2DM in RA patients.
- Complement C3, in conjunction with RA duration, offers a valuable tool for identifying RA patients at higher risk for T2DM.
Background:
Recent evidence demonstrated a potential role of complement C3 as a candidate biomarker of cardiometabolic risk in the general population.
Objective:
Aim of the present study was to investigate the correlation between complement C3 levels and comorbid Type 2 Diabetes (T2DM) in Rheumatoid Arthritis (RA) patients.
Methods:
For the present study, 40 consecutive diabetic RA patients (RA/T2DM+ group) and 80 consecutive RA patients without diabetes (RA/T2DM- group) were recruited.
Results:
Patients in the RA/T2DM+ group were significantly older (p < 0.0001), had a longer RA duration (p < 0.0001) and higher disease activity (p = 0.006) compared to controls. Moreover, patients in the RA/T2DM+ group had significantly higher levels of ESR (p < 0.0001), CRP (p < 0.0001) and complement C3 (p < 0.0001). A logistic regression model was built to ascertain the effect of selected variables (age, RA duration, BMI, ESR, C3, lnCRP, corticosteroid use) on the likelihood that patients have T2DM. Longer RA duration, ESR and C3 were associated with an increased likelihood of being classified as T2DM. Finally, we built ROC curves to evaluate the predictivity of RA duration, complement C3 and the combination of both variables on the likelihood of being diagnosed with T2DM. The area under the ROC curve was 0.79 (p < 0.0001) for RA duration, 0.71 (p < 0.0001) for complement C3 and 0.89 (p < 0.0001) for the combination of both variables.
Conclusion:
According to our data complement C3 levels can predict the presence of T2DM in RA patients.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
09:31Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Serum Studies: Renal Function Tests
Serum Laboratory Studies, Stool Test, Breath Test
Complement System